Related Experiment Video
Updated: Jun 11, 2025
07:48
Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis
Published on: January 7, 2019
6.9K
Mini review of first-in-human integrin αvβ6 PET tracers
Richard H Kimura1, Andrei Iagaru1, H Henry Guo1
1Department of Radiology, Stanford University School of Medicine, Stanford, CA, United States.
Frontiers in Nuclear Medicine
|October 2, 2024
Summary
Head-to-tail cyclized peptide PET tracers show different biodistribution than linear or disulfide-bonded ones. This impacts their use in imaging diseases like cancer and long COVID.
Area of Science:
- Oncology
- Radiochemistry
- Molecular Imaging
Background:
- Integrin αvβ6 is a target for PET imaging in various diseases.
- PET tracers are crucial for visualizing disease-specific biomarkers.
- Understanding tracer biodistribution is key for accurate clinical interpretation.
Purpose of the Study:
- To review and compare the human biodistribution patterns of clinically-evaluated integrin αvβ6 PET tracers.
- To identify differences between linear, disulfide-stabilized, and cyclized peptide-based PET tracers.
- To assess the clinical utility of various αvβ6 PET tracers for disease detection.
Main Methods:
- Mini-review of published clinical data on integrin αvβ6 PET tracers.
- Analysis of biodistribution patterns in humans for different peptide formats.
- Evaluation of tracer affinity and disease delineation capabilities.
Main Results:
- All reviewed PET tracers could differentiate diseased from normal tissues.
- Head-to-tail cyclized peptides showed no GI-tract accumulation, unlike linear/disulfide-bonded counterparts.
- Linear and disulfide-bonded tracers are under clinical evaluation for cancer, IPF, and long COVID.
Conclusions:
- Distinct human biodistribution patterns exist between different integrin αvβ6 PET tracer formats.
- Cyclized peptide tracers may offer advantages by avoiding GI-tract accumulation.
- Further research is needed to fully understand and optimize human αvβ6-imaging.
More Related Videos
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
91
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
91
01:29Positron Emission Tomography
4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K